ストックスクリーナーアプリを入手
16.60
1.95%
-0.33
アフターアワーズ：
16.60
前日終値:
$16.93
開ける：
$17.15
24時間の取引高:
1.32M
Relative Volume:
1.25
時価総額：
$1.72B
収益：
$71.78M
当期純損益:
$-295.28M
株価収益率:
-5.2537
EPS:
-3.1597
ネットキャッシュフロー:
$-271.85M
1週間 パフォーマンス:
-2.81%
1か月 パフォーマンス:
+7.03%
6か月 パフォーマンス:
+33.28%
1年 パフォーマンス:
+51.74%
1日の値動き範囲:
$16.06
$17.39
1週間の範囲:
$16.06
$17.39
52週間の値動き範囲:
$8.195
$22.50
Nurix Therapeutics Inc Stock (NRIX) Company Profile
名前
Nurix Therapeutics Inc
セクター
電話
(415) 660-5320
住所
1600 SIERRA POINT PKWY, BRISBANE
Compare NRIX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
16.60 | 1.75B | 71.78M | -295.28M | -271.85M | -3.1597 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-03-17 | 開始されました | Leerink Partners | Market Perform |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-11 | 開始されました | Jefferies | Buy |
| 2024-09-06 | 再開されました | Robert W. Baird | Outperform |
| 2024-07-31 | 開始されました | Truist | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-03-09 | 開始されました | Barclays | Overweight |
| 2023-02-28 | 開始されました | Oppenheimer | Outperform |
| 2022-10-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 開始されました | Wells Fargo | Equal Weight |
| 2021-12-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-30 | 再開されました | Piper Sandler | Overweight |
| 2021-04-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-11-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | Stifel | Buy |
すべてを表示
Nurix Therapeutics Inc (NRIX) 最新ニュース
Houte Hans Van Sells 14,055 Shares of Nurix Therapeutics (NASDAQ:NRIX) Stock - MarketBeat
Nurix CFO Hans van Houte sells $233k in company stock - Investing.com
Nurix Therapeutics (NRIX) CFO sells 14,055 shares in planned trade - Stock Titan
Insider Sell: Christine Ring Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
[144] Nurix Therapeutics, Inc. SEC Filing - Stock Titan
Nurix Therapeutics chief legal officer sells $138k in stock - Investing.com
Nurix Therapeutics (NRIX) CLO sells 8,148 shares in planned trade - Stock Titan
Form 144: Christine Ring to sell NRIX shares (NRIX) - Stock Titan
(NRIX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock - Investing.com
Nurix Therapeutics (NRIX) legal chief sells 5,394 shares in planned trade - Stock Titan
Issuer (NASDAQ: NRIX) reports proposed RSU sale by executive - Stock Titan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares By Investing.com - Investing.com Australia
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 Shares - MarketBeat
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of Stock - MarketBeat
Nurix therapeutics CSO Hansen sells $53,497 common stock - Investing.com UK
Nurix therapeutics CSO Hansen sells $53,497 common stock By Investing.com - Investing.com India
Nurix therapeutics CFO Hans van Houte sells $39,748 in shares By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares - Investing.com
Nurix (NRIX) CFO nets shares after RSU vesting tax sale - Stock Titan
Tax-driven share sale and RSU vesting for Nurix (NRIX) - Stock Titan
Nurix (NRIX) CSO Hansen converts RSUs, sells 3,214 shares to cover taxes - Stock Titan
Pictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
California Biopharma Co. Uncovers Massive Oncology Breakthrough - Streetwise Reports
Nurix Therapeutics shares edge higher despite Q1 earnings miss - MSN
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - MSN
Institutional Investors Accumulate Nurix Therapeutics Stock on TPD Leadership - HarianBasis.co
Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money - Insider Monkey
NRIX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $32 - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Nurix stock, $32 target - Investing.com UK
H.C. Wainwright reiterates Buy on Nurix stock, $32 target By Investing.com - Investing.com Australia
Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential - Insider Monkey
Assessing Nurix Therapeutics (NRIX) Valuation After New AACR 2026 Oncology Data - Sahm
Redmile (NRIX) holds 10.7M shares — 9.9% including warrants - Stock Titan
Nurix Therapeutics (NRIX) Receives a Buy from Piper Sandler - The Globe and Mail
Does Nurix Therapeutics (NRIX) have the potential to rally 85.84% as Wall Street analysts expect? - MSN
NRIX Reiterates by Needham -- Price Target Maintained at $26 - GuruFocus
Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics Inc (NRIX) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):